Cervical Cancer Diagnostic Test Market (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC)  and Forecast, 2015 – 2021

Cervical Cancer Diagnostic Test Market (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Forecast, 2015 – 2021

Comments Off on Cervical Cancer Diagnostic Test Market (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Forecast, 2015 – 2021

According to the report, the global cervical cancer diagnostic market accounted for USD 6.70 billion in 2015 and is expected to reach USD 9.46 by 2021, growing at a CAGR of around 5.9% between 2015 and 2021.Cervical cancer is an abnormal growth of cervical cells in the cervix. Cervical cancer commonly spread through a virus termed as human papilloma virus (HPV). Most of the cervical cancer is caused due to HPV 16 and HPV 18 virus. The same viruses are also responsible for causing anal cancer and penile cancer in men. However, HPV 6 and HPV 11 are commonly associated with causing genital warts. With the growing number of cervical cancer diagnostic tests such as Pap smear tests, HPV testing and colposcopy for early detection, the demand of such market is described as highly competitive with high growth rate.




According to the report, the global cervical cancer diagnostic market accounted for USD 6.70 billion in 2015 and is expected to reach USD 9.46 by 2021, growing at a CAGR of around 5.9% between 2015 and 2021.

Cancer is defined as abnormal growth of cells with the potential to spread to other parts of the body. There are various types of cancer affecting different parts of the body. Cancer which develops in the cervix is called as cervical cancer. Two major types of cervical cancers diagnosed in women include adenocarcinoma and squamous cell carcinoma. Almost all types of cervical cancer are caused by human papiloma virus (HPV). Cervical cancer is the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for almost 3,00,000 deaths annually. Diagnosis of cervical cancer is done by pap smear tests, colposcopy, HPV testing, endocervical curettage (ECC). Cervical cancer is a sexually transmitted disease that can be prevented by early detection and vaccination.

Globally, cervical cancer diagnostic test market has been accelerated by increasing the percentage of HPV infected female population across the globe. According to the Center for Disease Control and Prevention (CDC), six million people in the U.S. acquire HPV each year.  At least 20 million already suffer from cervical cancer, and more than half of all sexually-active adults will be infected during their lifetime. Furthermore increasing the incidence of weakened immune system coupled with certain life history is also considered as a major governing factor which promotes the cause of cervical cancer in female and thus promotes the cervical cancer diagnostic market. Moreover many lifestyle-related factors, such as having multiple sex partners, smoking, obesity, unsafe sex and inherited HPV-positive patient, are estimated to drive the cervical diagnostics market. However, lack of education regarding the prevalence of cervical cancer and the unwillingness of the female population to undergo cervical cancer prognosis would hinder the growth of the market. In addition, HPV vaccination which makes people hesitant for conducting cervical cancer diagnostic test is also one of the restraining factors in a growth of cervical cancer diagnostic market.

Cervical Cancer Diagnostic Test

Based on the test, the global market of cervical cancer diagnostic test is bifurcated into five types: Pap smear tests, colposcopy, HPV testing, endocervical curettage (ECC) and others (Cone Biopsy and Loop Electrosurgical Excision Procedure). The Pap smear tests segment accounted for the largest share of approximately more than 50% of the total cervical cancer diagnostic tests market in 2015. Factors attributed to the dominance of Pap smear tests are lower test prices and growing awareness about cancer diagnosis and benefits of early detection. Similarly, the HPV testing is forecast to grow at the fastest growth rate of approximately more than 9% from 2015 to 2021 of the cervical cancer diagnostic tests market. The rapid growth of the HPV testing segment is attributed due to the increasing incidence of HPV infections and risk of abnormal Pap test.

Based on end-user, the global market of cervical cancer diagnostics/test is bifurcated into three types: hospitals, laboratories, and others. The hospital’s segment was the leading segment in 2015. The segment is expected to continue its dominance during the forecast period.

Based on geographies, the global market of cervical cancer diagnostics/test is bifurcated into five regions: North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India, and Brazil. North America accounted for the largest share of the global cervical cancer diagnostics/test market, followed by Europe. This growth is attributed due to rising awareness related to health care in this region. Moreover, cervical cancer diagnostics/test market has the huge opportunity in the emerging markets of Asia Pacific due to increasing standard of living, large patient base in this region. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of cervical cancer, increasing government support, and growing upper middle-class population and rise in disposable income levels in this region.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global cervical cancer diagnostic test market include Abbott Laboratories, Becton, Dickinson and Company, Femasys, Inc., Hologic, Inc., Guided Therapeutics, Inc., OncoHealth Corp., Quest Diagnostics, Inc., Roche Diagnostics, QIAGEN, and Zilico Ltd.

  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Cervical Cancer Diagnostic Test Market, 2015 – 2021 (USD Billion)
    • 2.2. Global Cervical Cancer Diagnostic Test Market: Snapshot
  • Chapter 3. Cervical Cancer Diagnostic Test – Market Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Global Cervical Cancer Diagnostic Test Market Drivers: Impact Analysis
      • 3.3.2. Rapid Spread Of Human Papillomavirus (HPV) Infection
      • 3.3.3. Having Multiple Sex Partners
    • 3.4. Market Restraints
      • 3.4.1. Global Cervical Cancer Diagnostic Test Market Restraints: Impact Analysis
      • 3.4.2. Lack Of Education Regarding The Prevalence Of Cervical Cancer
    • 3.5. Opportunities
      • 3.5.1. Covering Untapped Market
    • 3.6. Porter’s Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. Threat From New Entrants
      • 3.6.4. Threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, By Test Segment
      • 3.7.2. Market Attractiveness Analysis, By End- Users Segment
      • 3.7.3. Market Attractiveness Analysis, By Regional Segment
  • Chapter 4. Global Cervical Cancer Diagnostic Test Market – Competitive Landscape
    • 4.1. Company Market Share, 2015 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
      • 4.2.4. Research And Development, Regional Expansion
    • 4.3. Type Portfolio
  • Chapter 5. Global Cervical Cancer Diagnostic Test Market – Test Analysis
    • 5.1. Global Cervical Cancer Diagnostic Test Market: Test Overview
      • 5.1.1. Global Cervical Cancer Diagnostic Test Market Revenue Share, By Test , 2015 And 2021
    • 5.2. Pap Smear Tests
      • 5.2.1. Global Pap Smear Tests Market, 2015 – 2021 (USD Billion)
    • 5.3. Colposcopy
      • 5.3.1. Global Colposcopy Market, 2015 – 2021 (USD Billion)
    • 5.4. HPV Testing
      • 5.4.1. Global HPV Testing Market, 2015 – 2021 (USD Billion)
    • 5.5. Endocervical Curettage (ECC)
      • 5.5.1. Global Endocervical Curettage (ECC) Market, 2015 – 2021 (USD Billion)
    • 5.6. Others
      • 5.6.1. Global Other Cervical Cancer Diagnostic Test Market, 2015 – 2021 (USD Billion)
  • Chapter 6. Global Cervical Cancer Diagnostic Test Market – End- Users Analysis
    • 6.1. Global Cervical Cancer Diagnostic Test Market: End- Users Segment Overview
      • 6.1.1. Global Cervical Cancer Diagnostic Test Market Revenue Share, By End- Users, 2015 And 2021
    • 6.2. Hospitals
      • 6.2.1. Global Cervical Cancer Diagnostic Test Market For Hospitals , 2015 – 2021 (USD Billion)
    • 6.3. Laboratories
      • 6.3.1. Global Cervical Cancer Diagnostic Test Market For Laboratories, 2015 – 2021 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global Cervical Cancer Diagnostic Test For Others End- Users Market, 2015 – 2021 (USD Billion)
  • Chapter 7. Global Cervical Cancer Diagnostic Test Market – Regional Segment Analysis
    • 7.1. Global Cervical Cancer Diagnostic Test Market: Regional Overview
      • 7.1.1. Global Cervical Cancer Diagnostic Test Market Revenue Share, By Region, 2015 And 2021
    • 7.2. North America
      • 7.2.1. North America Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 , (USD Billion)
      • 7.2.2. North America Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 , (USD Billion)
      • 7.2.3. U.S.
        • 7.2.3.1. U.S. Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.3.2. Europe Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.3.3. Germany
        • 7.3.3.1. Germany Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021, (USD Billion)
        • 7.3.3.2. Germany Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021, (USD Billion)
      • 7.3.4. France
        • 7.3.4.1. France Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021, (USD Billion)
        • 7.3.4.2. France Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021, (USD Billion)
      • 7.3.5. UK
        • 7.3.5.1. UK Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.3.5.2. UK Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.4.2. Asia Pacific Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.4.3.2. China Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.4.4.2. Japan Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.4.5.2. India Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.5.2. Latin America Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
        • 7.5.3.2. Brazil Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
    • 7.6. Middle East And Africa
      • 7.6.1. Middle East And Africa Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021 (USD Billion)
      • 7.6.2. Middle East And Africa Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021 (USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Abbott Laboratories
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Becton, Dickinson and Company
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Femasys, Inc.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Hologic, Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Guided Therapeutics, Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. OncoHealth Corp.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments
    • 8.7. Quest Diagnostics, Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Developments
    • 8.8. Roche Diagnostics
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments
    • 8.9. QIAGEN
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Developments
    • 8.10. Zilico Ltd
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Developments

List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global Cervical Cancer Diagnostic Test  Market Revenue, 2015 – 2021 (USD Billion)
4. Porter’s Five Forces Analysis
5. Cervical Cancer Diagnostic Test : Market Attractiveness Analysis, By Test  Segment
6. Cervical Cancer Diagnostic Test : Market Attractiveness Analysis, By End- Users Segment
7. Cervical Cancer Diagnostic Test  : Market Attractiveness Analysis, By Regional Segment
8. Company Market Share Analysis, 2015 And 2021
9. Global Cervical Cancer Diagnostic Test Market Revenue Share By Test , 2015 And 2021
10. Pap Smear Tests Market, 2015 – 2021, (USD Billion)
11. Colposcopy Test Market, 2015 – 2021, (USD Billion)
12. HPV Testing Market, 2015 – 2021, (USD Billion)
13. Endocervical Curettage (ECC) Diagnostic Test Market, 2015 – 2021, (USD Billion)
14. Other Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
15. Global Cervical Cancer Diagnostic Test Market Revenue Share By End- Users, 2015 And 2021
16. Cervical Cancer Diagnostic Test Market for Laboratories, 2015 – 2021, (USD Billion)
17. Cervical Cancer Diagnostic Test Market for Hospitals, 2015 – 2021, (USD Billion)
18. Cervical Cancer Diagnostic Test Market for Other End- Users, 2015 – 2021, (USD Billion)
19. Global Cervical Cancer Diagnostic Test Market Share, By Region, 2015 – 2021
20. North America Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
21. U.S. Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
22. Europe Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
23. UK Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
24. France Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
25. Germany Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
26. Asia Pacific Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
27. China Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
28. Japan Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
29. India Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
30. Latin America Cervical Cancer Diagnostic Test Market, 2015-2021, (USD Billion)
31. Brazil Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)
32. Middle East & Africa Cervical Cancer Diagnostic Test Market, 2015 – 2021, (USD Billion)


List of Tables

1. Cervical Cancer Diagnostic Test Market: Market Snapshot
2. Drivers Of Global Cervical Cancer Diagnostic Test Market: Impact Analysis
3. Restraints Of Global Cervical Cancer Diagnostic Test Market: Impact Analysis
4. North America Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021(USD Billion)
5. North America Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021(USD Billion)
6. US Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021(USD Billion)
7. US Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021(USD Billion)
8. Europe Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021(USD Billion)
9. Europe Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021(USD Billion)
10. UK Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021(USD Billion)
11. UK Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021(USD Billion)
12. France Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021(USD Billion)
13. France Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021(USD Billion)
14. Germany Cervical Cancer Diagnostic Test Market Revenue, By Test , 2015 – 2021(USD Billion)
15. Germany Cervical Cancer Diagnostic Test Market Revenue, By End- Users, 2015 – 2021(USD Billion)
16. Asia Pacific Cervical Cancer Diagnostic Test Market Revenue, By Test 2015 – 2021(USD Billion)
17. Asia Pacific Cervical Cancer Diagnostic Test Market Revenue, By End- Users 2015 – 2021(USD Billion)
18. Latin America Cervical Cancer Diagnostic Test Market Revenue, By Test – 2021 (USD Billion)
19. Latin America Cervical Cancer Diagnostic Test Market Revenue, By End- Users – 2021 (USD Billion)
20. Brazil Cervical Cancer Diagnostic Test Market Revenue, By Test – 2021 (USD Billion)
21. Brazil Cervical Cancer Diagnostic Test Market Revenue, By End- Users – 2021 (USD Billion)
22. Middle East And Africa Cervical Cancer Diagnostic Test Market Revenue, By Test – 2021 (USD Billion)
23. Middle East And Africa Cervical Cancer Diagnostic Test Market Revenue, By End- Users – 2021 (USD Billion)

* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly



Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account